Login / Signup

Purification and characterization of fibrinolytic protease from Streptomyces parvulus by polyethylene glycol-phosphate aqueous two-phase system.

Viviane N S AlencarMaria Clara DO NascimentoJulyanne V Dos Santos FerreiraJuanize Matias da Silva BatistaMarcia N C DA CunhaJéssica M DO NascimentoRenata V DA Silva SobralMilena T T DO CoutoThiago Pajeú NascimentoRomero Marcos Pedrosa Brandão CostaAna Lucia Figueiredo PortoAna Cristina L Leite
Published in: Anais da Academia Brasileira de Ciencias (2021)
Fibrinolytic proteases are a promising alternative in the pharmaceutical industry, they are used in the treatment of cardiovascular diseases, especially thrombosis. Microorganisms are the most interesting source of fibrinolytic proteases. The aim of this study was the production of fibrinolytic protease from Streptomyces parvulus DPUA 1573, the recovery of the protease by aqueous two-phase system and partial biochemical characterization of the enzyme. The aqueous two-phase system was performed according to a 24-full factorial design using polyethylene glycol molar mass, polyethylene glycol concentration, citrate concentration and pH as independent variables. It was analyzed the effect of different ions, surfactants, inhibitors, pH and temperature on enzyme activity. The best conditions for purifying the enzyme were 17.5% polyethylene glycol 8,000, 15% Phosphate and pH 8.0, it was obtained a partition coefficient of 7.33, a yield of 57.49% and a purification factor of 2.10-fold. There was an increase in enzyme activity in the presence of Fe2+ and a decrease in the presence of $\beta$-Mercaptoethanol, phenylmethylsulfonyl fluoride and Iodoacetic acid. The optimum pH was 7.0 and the optimum temperature was 40 ºC. The purified protease exhibited a molecular mass of 41 kDa. The fibrinolytic protease from Streptomyces parvulus proved to be a viable option for the development of a possible drug with fibrinolytic action.
Keyphrases
  • cardiovascular disease
  • ionic liquid
  • pulmonary embolism
  • computed tomography
  • coronary artery disease
  • single molecule
  • drug induced
  • recombinant human